Elevance Health (ELV) Debt to Equity (2009 - 2026)

Elevance Health (ELV) has 18 years of Debt to Equity data on file, last reported at $0.72 in Q1 2026.

• Debt to Equity for Q1 2026 came in at $0.72, up 2.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.72 (up 2.75% YoY), and the FY2025 annual result was $0.71, down 1.24% from the prior year.
• Debt to Equity grew to $0.72 in Q1 2026 per ELV's latest filing, from $0.71 in the prior quarter.
• Over five years, Debt to Equity peaked at $0.72 in Q3 2025 and troughed at $0.56 in Q1 2022.
• A 5-year average of $0.65 and a median of $0.65 in 2022 frame the typical range for Debt to Equity.
• The sharpest annual moves came in 2022 and 2023: Debt to Equity declined 18.39% in 2022, then advanced 20.34% in 2023.
• A 5-year view of Debt to Equity shows it stood at $0.66 in 2022, then decreased by 3.76% to $0.63 in 2023, then climbed by 13.03% to $0.71 in 2024, then declined by 1.24% to $0.71 in 2025, then increased by 1.71% to $0.72 in 2026.
• Business Quant data shows ELV's Debt to Equity at $0.72 in Q1 2026, $0.71 in Q4 2025, and $0.72 in Q3 2025.